Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Mariem Salhi, Oussama Lahmar, Marwa Ouled Salah, Ivana Banić, Bao Binghao, Waqar Malik, Kamel Hamzaoui, Mirjana Turkalj & Agnes Hamzaoui. (2021) GLCCI1 and STIP1 variants are associated with asthma susceptibility and inhaled corticosteroid response in a Tunisian population. Journal of Asthma 58:2, pages 197-206.
Read now
Read now
Christian L. Hvas, Mia Bendix, Anders Dige, Jens F. Dahlerup & Jørgen Agnholt. (2018) Current, experimental, and future treatments in inflammatory bowel disease: a clinical review. Immunopharmacology and Immunotoxicology 40:6, pages 446-460.
Read now
Read now
Jesús K Yamamoto-Furusho. (2017) Pharmacogenetics in inflammatory bowel disease: understanding treatment response and personalizing therapeutic strategies. Pharmacogenomics and Personalized Medicine 10, pages 197-204.
Read now
Read now
Xiaolan Guo & Ming Yan. (2017) Pregnane X Receptor Polymorphisms and Risk of Inflammatory Bowel Disease: A Meta-Analysis. Immunological Investigations 46:6, pages 566-576.
Read now
Read now
Articles from other publishers (17)
Min Li, Fang Wang, Ce Zhang, Min-An Li, Tian Wang, Yu-Chen Li & Feng-Hua Fu. (2022) Integrated systematic pharmacology analysis and experimental validation to reveal the mechanism of action of Semen aesculi on inflammatory bowel diseases. Journal of Ethnopharmacology 298, pages 115627.
Crossref
Crossref
Yumeng Dong, Tiangang Xu, Guozheng Xiao, Ziyan Hu & Jingyu Chen. (2022) Opportunities and challenges for synthetic biology in the therapy of inflammatory bowel disease. Frontiers in Bioengineering and Biotechnology 10.
Crossref
Crossref
Dorota Skrzypczak, Marzena Skrzypczak-Zielińska, Alicja Ewa Ratajczak, Aleksandra Szymczak-Tomczak, Piotr Eder, Ryszard Słomski, Agnieszka Dobrowolska & Iwona Krela-Kaźmierczak. (2021) Myostatin and Follistatin—New Kids on the Block in the Diagnosis of Sarcopenia in IBD and Possible Therapeutic Implications. Biomedicines 9:10, pages 1301.
Crossref
Crossref
Arno C. Hessels, Jan Stephan F. Sanders, Abraham Rutgers & Coen A. Stegeman. (2020) Gene variants and treatment outcomes in antineutrophil cytoplasmic antibody-associated vasculitis. The Pharmacogenomics Journal 20:6, pages 749-759.
Crossref
Crossref
Thomas Kuhn, Marcus Koch & Gregor Fuhrmann. (2020)
Probiomimetics—Novel
Lactobacillus
‐Mimicking Microparticles Show Anti‐Inflammatory and Barrier‐Protecting Effects in Gastrointestinal Models
. Small 16:40, pages 2003158.
Crossref
Crossref
M. Bastin & F. Andreelli. (2020) Diabète et corticoïdes : nouveautés et aspects pratiques. La Revue de Médecine Interne 41:9, pages 607-616.
Crossref
Crossref
Simona Ronchetti, Marco Gentili, Erika Ricci, Graziella Migliorati & Carlo Riccardi. (2020) Glucocorticoid-Induced Leucine Zipper as a Druggable Target in Inflammatory Bowel Diseases. Inflammatory Bowel Diseases 26:7, pages 1017-1025.
Crossref
Crossref
Qiao-Mei Xie, Qiu-Yue Lou, Shun-Wei Huang, Hua-Qing Hu, Su-Su Li, Man Zhang, Xiu-Xiu Sun, Jian-Hua Xu, Shan-Qun Jiang, Sheng-Xiu Liu, Sheng-Qian Xu, Jing Cai, Shuang Liu, Fa-Ming Pan, Jin-Hui Tao, Long Qian, Chun-Huai Wang, Chun-Mei Liang, Hai-Liang Huang, Hai-Feng Pan, Hong Su & Yan-Feng Zou. (2020) Hsp70 Gene Polymorphisms Are Associated With Disease Susceptibility and HRQOL Improvement in Chinese Han Population With Systemic Lupus Erythematosus. JCR: Journal of Clinical Rheumatology 26:4, pages 134-141.
Crossref
Crossref
Astrid Eliasen, Kim Dalhoff, René Mathiasen, Kjeld Schmiegelow, Catherine Rechnitzer, Astrid Blicher Schelde, Dyah Aryani Perwitasari, Daiki Tsuji & Jesper Brok. (2020) Pharmacogenetics of antiemetics for chemotherapy-induced nausea and vomiting: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology 149, pages 102939.
Crossref
Crossref
Michael W. Winter & Joel V. Weinstock. 2020. The Autoimmune Diseases. The Autoimmune Diseases
871
894
.
Mushref Bakri Assas, Scott Levison & Joanne L. Pennock. (2019) Early induction of C/EBPβ expression as a potential marker of steroid responsive colitis. Scientific Reports 9:1.
Crossref
Crossref
Andrzej Hnatyszyn, Marlena Szalata, Marzena Skrzypczak-Zielinska, Karolina Wielgus, Jerzy Stanczyk, Ireneusz Dziuba, Adam Mikstacki, Agnieszka Dobrowolska, Malgorzata Waszak, Piotr Tomasz Hnatyszyn & Ryszard Slomski. (2019) DNA variants in Helicobacter pylori infected patients with chronic gastritis, dysplasia and gastric cancer. Advances in Medical Sciences 64:1, pages 79-84.
Crossref
Crossref
Ho-Su Lee & Isabelle Cleynen. 2019. Molecular Genetics of Inflammatory Bowel Disease. Molecular Genetics of Inflammatory Bowel Disease
157
182
.
Man Zhang, Su-Su Li, Qiao-Mei Xie, Jian-Hua Xu, Xiu-Xiu Sun, Fa-Ming Pan, Sheng-Qian Xu, Sheng-Xiu Liu, Jin-Hui Tao, Shuang Liu, Jing Cai, Pei-Ling Chen, Long Qian, Chun-Huai Wang, Chun-Mei Liang, Hai-Liang Huang, Hai-Feng Pan, Hong Su & Yan-Feng Zou. (2018) Associations of HSP90AA2 gene polymorphisms with disease susceptibility, glucocorticoids efficacy and health-related quality of life in Chinese systemic lupus erythematosus patients. Genes & Genomics 40:10, pages 1069-1079.
Crossref
Crossref
Aghil Ibrahim, Per Dahlqvist, Tommy Olsson, David Lundgren, Mårten Werner, Ole B. Suhr & Pontus Karling. (2017) The clinical course after glucocorticoid treatment in patients with inflammatory bowel disease is linked to suppression of the hypothalamic–pituitary–adrenal axis: a retrospective observational study. Therapeutic Advances in Gastroenterology 10:11, pages 829-836.
Crossref
Crossref
J. Banuelos, Y. Cao, S. C. Shin & N. Z. Lu. (2017) Immunopathology alters Th17 cell glucocorticoid sensitivity. Allergy 72:3, pages 331-341.
Crossref
Crossref
Min Li, Feng-hua Fu, Fang Wang, Ce Zhang, Min-an Li, Tian Wang & Yu-chen Li. (2022) Integrated Systematic Pharmacology Analysis and Experimental Validation to Reveal the Mechanism of Action of Semen Aesculi on Inflammatory Bowel Diseases. SSRN Electronic Journal.
Crossref
Crossref